Cetera Investment Advisers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.5M Sell
267,714
-28,937
-10% -$2M 0.03% 549
2025
Q1
$20.6M Buy
296,651
+46,169
+18% +$3.21M 0.04% 456
2024
Q4
$21.5M Sell
250,482
-36,846
-13% -$3.17M 0.05% 401
2024
Q3
$34.2M Sell
287,328
-3,517
-1% -$419K 0.07% 265
2024
Q2
$41.5M Buy
290,845
+25,307
+10% +$3.61M 0.1% 207
2024
Q1
$34.1M Buy
265,538
+217,545
+453% +$27.9M 0.08% 252
2023
Q4
$4.96M Buy
47,993
+2,693
+6% +$279K 0.04% 435
2023
Q3
$4.12M Buy
45,300
+1,678
+4% +$153K 0.04% 478
2023
Q2
$3.53M Buy
43,622
+1,872
+4% +$151K 0.03% 535
2023
Q1
$3.32M Sell
41,750
-840
-2% -$66.8K 0.03% 529
2022
Q4
$2.88M Buy
42,590
+14,290
+50% +$967K 0.03% 569
2022
Q3
$1.41M Sell
28,300
-4,668
-14% -$233K 0.03% 583
2022
Q2
$1.84M Buy
32,968
+7,256
+28% +$404K 0.03% 566
2022
Q1
$1.43M Sell
25,712
-866
-3% -$48.1K 0.02% 687
2021
Q4
$1.49M Buy
26,578
+564
+2% +$31.6K 0.02% 654
2021
Q3
$1.25M Buy
26,014
+2,988
+13% +$143K 0.02% 695
2021
Q2
$964K Buy
23,026
+2,082
+10% +$87.2K 0.02% 791
2021
Q1
$706K Sell
20,944
-3,686
-15% -$124K 0.01% 810
2020
Q4
$860K Buy
24,630
+12,596
+105% +$440K 0.02% 726
2020
Q3
$418K Buy
12,034
+5,334
+80% +$185K 0.03% 419
2020
Q2
$219K Sell
6,700
-10,608
-61% -$347K 0.02% 557
2020
Q1
$521K Sell
17,308
-426
-2% -$12.8K 0.06% 295
2019
Q4
$514K Buy
17,734
+1,088
+7% +$31.5K 0.05% 336
2019
Q3
$431K Buy
16,646
+4,836
+41% +$125K 0.05% 331
2019
Q2
$300K Sell
11,810
-696
-6% -$17.7K 0.04% 385
2019
Q1
$326K Sell
12,506
-270
-2% -$7.04K 0.05% 361
2018
Q4
$295K Buy
12,776
+1,458
+13% +$33.7K 0.05% 342
2018
Q3
$268K Buy
+11,318
New +$268K 0.04% 393